Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal
Stat News • 9/30/2026 – 10/1/2026
Summary
The Trump administration published a final rule to lower Medicare prices for drugs administered in doctor offices. This rule applies to only four companies and saves 96% less than the initial proposal.
Advertisement
Lindy Score Breakdown (V4.2)
1h
Age
1
Sources
from cluster
2
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier97% (0.5^2/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms
Stat News • 1 day ago
STAT+: Eli Lilly’s Zepbound combined with amylin drug led to significant weight loss in mid-stage trial
Stat News • Today
STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
Stat News • Today
STAT+: The last ‘breakthrough’ devices to get special treatment from Medicare
Stat News • 1 day ago
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
Stat News • 1 day ago
STAT+: UnitedHealth investor lawsuit moves forward on allegations it ‘manufactured earnings’ to hide declining profits
Stat News • Today
Researchers slow neurodegeneration in mice by barring T cells from the brain
Stat News • 1 day ago
Kratom and 7-OH should be regulated, experts agree. They’re split on how
Stat News • Today
STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader
Stat News • Today
STAT+: AbbVie wins FDA nod for Parkinson’s pill
Stat News • 2 days ago